Market Overview:
The global transdermal drug delivery patches market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in transdermal drug delivery patches. Based on type, the global transdermal drug delivery patches market is segmented into methyl salicylate-based patch, rivastigmine transdermal patch, fentanyl transdermal patch, lidocaine patch, diclofenac patch, nicotine transdermal patch and others.
Product Definition:
A transdermal drug delivery patch is a medicated adhesive patch that is placed on the skin to deliver a dose of medication through the skin and into the bloodstream. The patch works by delivering medication continuously for 24 hours or more, which allows for less frequent dosing. This type of drug delivery system can be used to administer many different types of medications, including pain relievers, psychiatric drugs, and birth control.
Methyl Salicylate-based Patch:
Methyl salicylate-based patch is a transdermal drug delivery system that uses the principle of oleoresin to convey drugs. Methyl salicylate based patches are used for the treatment of skin diseases such as psoriasis and eczema. The oleoresin contains approximately 50% concentration of methyl salicylate which acts as an effective vehicle for delivering drugs to affected areas.
Rivastigmine Transdermal Patch:
Rivastigmine transdermal patch is used for the treatment of Alzheimer's disease and dementia. It works by improving the ability of the brain to use glucose as fuel, thereby increasing energy levels in patients suffering from these diseases. The drug is administered every two weeks and helps improve cognitive functioning, which further improves patient’s ability to carry out daily activities.
Application Insights:
The market is segmented based on application into prescription and over the counter (OTC) channel. The OTC channel held a major share of the global transdermal drug delivery patch market in 2017. This is attributed to growing awareness about health issues among individuals, especially in developing countries like India and China. In addition, rising incidences of skin disorders are also expected to boost demand for these patches in OTC applications during the forecast period.
Rising prevalence of chronic diseases, such as diabetes and cardiovascular diseases along with an increasing geriatric population across the globe is anticipated to drive demand for transdermal drug delivery patches over the forecast period owing to which application segments are expected to grow at a significant rate during this period.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and high disposable income. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by companies as well as government for developing innovative transdermal drug delivery systems. In addition, growing demand for patches that are non-invasive, convenient, and offer faster results is also expected to drive growth in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing rising awareness about these patches among patients as well as healthcare professionals. Growing demand from countries such as Japan and China coupled with improving healthcare infrastructure will drive growth further in this region. Moreover, an increase in chronic diseases such diabetes that require long term treatment may boost product adoption over here too during future years if proper studies are conducted on animals first then humans can use it too (this has not been done yet).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases such as heart disease, stroke, cancer, and diabetes accounted for 63% of all deaths in 2012. This number is expected to rise to 73% by 2030. This will create a large pool of patients who will require long-term treatment, which can be effectively delivered through transdermal drug delivery patches.
- Growing demand for minimally invasive treatments: Patients are increasingly preferring minimally invasive treatments over traditional surgery or medication therapies due to their shorter recovery times and fewer side effects. Transdermal drug delivery patches offer a number of advantages over other forms of drug delivery such as oral administration or injection therapy including reduced patient discomfort, improved patient compliance, and reduced healthcare costs. As a result, there is growing demand for transdermal drug delivery patches among both physicians and patients alike.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Drug Delivery Patches Market Research Report
By Type
Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Transdermal Patch, Others
By Application
Rx Channel, OTC Channel
By Companies
Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
189
Number of Tables & Figures
133
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Drug Delivery Patches Market Report Segments:
The global Transdermal Drug Delivery Patches market is segmented on the basis of:
Types
Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Transdermal Patch, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rx Channel, OTC Channel
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Teva Pharmaceutical
- Nitto Denko
- Grünenthal
- IBSA Group
- GSK
- Luye Pharma Group
- Pfizer
- Chattem
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Endo International
- Beijing Tide Pharmaceutical
Highlights of The Transdermal Drug Delivery Patches Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
- By Application:
- Rx Channel
- OTC Channel
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Drug Delivery Patches Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transdermal drug delivery patches are a type of medication that are placed on the skin and release the medication through the skin. This method is often used to deliver medications to areas where it is difficult for people to take pills, such as the stomach or intestines.
Some of the major companies in the transdermal drug delivery patches market are Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr¼nenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical.
The transdermal drug delivery patches market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transdermal Drug Delivery Patches Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Transdermal Drug Delivery Patches Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Transdermal Drug Delivery Patches Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Transdermal Drug Delivery Patches Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Transdermal Drug Delivery Patches Market Size & Forecast, 2018-2028
4.5.1 Transdermal Drug Delivery Patches Market Size and Y-o-Y Growth
4.5.2 Transdermal Drug Delivery Patches Market Absolute $ Opportunity
Chapter 5 Global Transdermal Drug Delivery Patches Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Transdermal Drug Delivery Patches Market Size Forecast by Type
5.2.1 Methyl Salicylate-based Patch
5.2.2 Rivastigmine Transdermal Patch
5.2.3 Fentanyl Transdermal Patch
5.2.4 Lidocaine Patch
5.2.5 Diclofenac Patch
5.2.6 Nicotine Transdermal Patch
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Transdermal Drug Delivery Patches Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Transdermal Drug Delivery Patches Market Size Forecast by Applications
6.2.1 Rx Channel
6.2.2 OTC Channel
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transdermal Drug Delivery Patches Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transdermal Drug Delivery Patches Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Transdermal Drug Delivery Patches Analysis and Forecast
9.1 Introduction
9.2 North America Transdermal Drug Delivery Patches Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Transdermal Drug Delivery Patches Market Size Forecast by Type
9.6.1 Methyl Salicylate-based Patch
9.6.2 Rivastigmine Transdermal Patch
9.6.3 Fentanyl Transdermal Patch
9.6.4 Lidocaine Patch
9.6.5 Diclofenac Patch
9.6.6 Nicotine Transdermal Patch
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Transdermal Drug Delivery Patches Market Size Forecast by Applications
9.10.1 Rx Channel
9.10.2 OTC Channel
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Transdermal Drug Delivery Patches Analysis and Forecast
10.1 Introduction
10.2 Europe Transdermal Drug Delivery Patches Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Transdermal Drug Delivery Patches Market Size Forecast by Type
10.6.1 Methyl Salicylate-based Patch
10.6.2 Rivastigmine Transdermal Patch
10.6.3 Fentanyl Transdermal Patch
10.6.4 Lidocaine Patch
10.6.5 Diclofenac Patch
10.6.6 Nicotine Transdermal Patch
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Transdermal Drug Delivery Patches Market Size Forecast by Applications
10.10.1 Rx Channel
10.10.2 OTC Channel
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Transdermal Drug Delivery Patches Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Transdermal Drug Delivery Patches Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Transdermal Drug Delivery Patches Market Size Forecast by Type
11.6.1 Methyl Salicylate-based Patch
11.6.2 Rivastigmine Transdermal Patch
11.6.3 Fentanyl Transdermal Patch
11.6.4 Lidocaine Patch
11.6.5 Diclofenac Patch
11.6.6 Nicotine Transdermal Patch
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Transdermal Drug Delivery Patches Market Size Forecast by Applications
11.10.1 Rx Channel
11.10.2 OTC Channel
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Transdermal Drug Delivery Patches Analysis and Forecast
12.1 Introduction
12.2 Latin America Transdermal Drug Delivery Patches Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Transdermal Drug Delivery Patches Market Size Forecast by Type
12.6.1 Methyl Salicylate-based Patch
12.6.2 Rivastigmine Transdermal Patch
12.6.3 Fentanyl Transdermal Patch
12.6.4 Lidocaine Patch
12.6.5 Diclofenac Patch
12.6.6 Nicotine Transdermal Patch
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Transdermal Drug Delivery Patches Market Size Forecast by Applications
12.10.1 Rx Channel
12.10.2 OTC Channel
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Transdermal Drug Delivery Patches Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Transdermal Drug Delivery Patches Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Transdermal Drug Delivery Patches Market Size Forecast by Type
13.6.1 Methyl Salicylate-based Patch
13.6.2 Rivastigmine Transdermal Patch
13.6.3 Fentanyl Transdermal Patch
13.6.4 Lidocaine Patch
13.6.5 Diclofenac Patch
13.6.6 Nicotine Transdermal Patch
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Transdermal Drug Delivery Patches Market Size Forecast by Applications
13.10.1 Rx Channel
13.10.2 OTC Channel
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transdermal Drug Delivery Patches Market: Competitive Dashboard
14.2 Global Transdermal Drug Delivery Patches Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hisamitsu Pharmaceutical
14.3.2 Johnson & Johnson
14.3.3 Novartis
14.3.4 UCB Pharma
14.3.5 Mylan
14.3.6 Teva Pharmaceutical
14.3.7 Nitto Denko
14.3.8 Grünenthal
14.3.9 IBSA Group
14.3.10 GSK
14.3.11 Luye Pharma Group
14.3.12 Pfizer
14.3.13 Chattem
14.3.14 Dr Reddy’s Laboratories
14.3.15 Bayer
14.3.16 Mundipharma
14.3.17 Endo International
14.3.18 Beijing Tide Pharmaceutical
